Analysis of Bacteriophage therapy market Strategies and Forecasts to 2035
With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
Type of Therapeutic Area
Infectious Diseases
Oncological Disorders
Other Disorders
Distribution by Route of Administration
Oral Route
Rectal Route
Intravesical Route
Topical Route
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
The “Bacteriophage Therapies Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
Adaptive Phage Therapeutics
ContaFect
Eliava BioPreparations
Micreos
NPO Microgen
Phagelux
Pherecydes Pharma
Table of Content
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. BACTERIO-PHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIO-PHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
6. COMPANY AND DRUG PROFILES
7. CLINICAL TRIAL ANALYSIS
8. PATENT ANALYSIS
9. PUBLICATION BENCHMARKING ANALYSIS
10. ACADEMIC GRANTS ANALYSIS
11. FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
13. START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
15. CONCLUSION
16. EXECUTIVE INSIGHTS
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/....reports/bacteriophag
Learn from experts: do you know about these emerging industry trends?
Rare Kidney Disorders: Future Miracle Drugs
Smart pharmaceutical and healthcare labels: Lets trace medicines from its origin
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#bacteriophagetherapeutics #bacteriophagetherapies #bacteriophagemarket #marketresearch #marketinsights
